Ridlip

Leaflet accompanying the packaging: patient information

Ridlip, 5 mg, film-coated tablets
Ridlip, 10 mg, film-coated tablets
Ridlip, 20 mg, film-coated tablets
Ridlip, 40 mg, film-coated tablets
Rosuvastatinum

You should carefully read the contents of the leaflet before taking the medicine, as it contains important information for the patient.

• You should keep this leaflet, so that you can read it again if necessary.
• In case of any doubts, you should consult a doctor or pharmacist.
• This medicine has been prescribed specifically for you. Do not pass it on to others. The medicine may harm another person, even if their symptoms are the same.
• If the patient experiences any side effects, including any side effects not listed in this leaflet, they should tell their doctor or pharmacist. See section 4.

Table of contents of the leaflet:

• 1. What is Ridlip and what is it used for
• 2. Important information before taking Ridlip
• 3. How to take Ridlip
• 4. Possible side effects
• 5. How to store Ridlip
• 6. Contents of the pack and other information

1. What is Ridlip and what is it used for

Ridlip belongs to a group of medicines called statins.

Ridlip is recommended for use because:

• The patient has been found to have high cholesterol levels. This means a risk of heart attack (myocardial infarction) or stroke. Ridlip is used in adults, adolescents, and children aged 6 years or older to treat high cholesterol levels.
• The doctor has prescribed a statin because diet and increased physical activity have proven insufficient to achieve normal cholesterol levels in the blood. The patient taking Ridlip should also follow a low-cholesterol diet and exercise regularly.

or

• Ridlip is also recommended if the patient has other factors that increase the risk of heart attack (myocardial infarction), stroke, or similar diseases.

Myocardial infarction, stroke, and other problems can be caused by atherosclerosis of the arteries.
Atherosclerosis of the arteries is the result of the deposition of atherosclerotic plaques in the blood vessels.

Why is it important to take Ridlip regularly

Ridlip is used to achieve normal levels of fatty substances in the blood.
The most common of these is cholesterol.
There are different types of cholesterol in the blood, so-called "bad" cholesterol (LDL-C) and "good" cholesterol (HDL-C).

• Ridlip may cause a decrease in "bad" cholesterol and an increase in "good" cholesterol.
• The action of Ridlip involves inhibiting the production of "bad" cholesterol in the body. It also helps to remove "bad" cholesterol from the blood.

In most people, high cholesterol levels do not change their well-being, as they do not cause any symptoms. However, if the patient does not receive treatment, it leads to the deposition of fatty substance deposits in the walls of blood vessels and their narrowing.
Sometimes, it may lead to the blockage of a narrowed blood vessel, disruption of blood flow to the heart or brain, and consequently to a heart attack or stroke. Achieving normal cholesterol levels in the blood reduces the risk of a heart attack, stroke, or similar diseases.

Even if the cholesterol level is normal after taking Ridlip, you should still

take it. This prevents the cholesterol level from rising again, which causes the deposition of fatty substances. You should stop taking Ridlip if your doctor advises you to do so or if you become pregnant.

2. Important information before taking Ridlip

When not to take Ridlip

• or any of the other ingredients of Ridlip,
• or breastfeeding. If a woman taking Ridlip becomes pregnant, she should stop taking it immediately and inform her doctor. Women taking Ridlip should use effective methods of contraception.
• ,
• ,
• ,
• (a medicine used, for example, after organ transplantation),

If any of the above situations apply to the patient or the patient has doubts, they should consult their doctor again.

In addition, do not take Ridlip, 40 mg (the highest dose):

• (in case of doubt, ask your doctor),
• ,
• , if the patient or their family members have had muscle diseases or previously experienced muscle disorders while taking cholesterol-lowering medicines,
• ,
• (Japanese, Chinese, Filipino, Vietnamese, Korean, or Indian),
• , i.e., other cholesterol-lowering medicines.

If any of the above situations apply to the patient (or the patient has doubts), they should consult their doctor again.

Warnings and precautions

Before starting to take Ridlip, you should consult your doctor or pharmacist,

• ;
• ;
• , or if the patient or their family members have had muscle diseases or previously experienced muscle disorders while taking cholesterol-lowering medicines. The patient should immediately consult their doctor if they experience muscle pain or weakness of unknown origin, especially if it is accompanied by general malaise and fever. They should also inform their doctor if they experience persistent muscle weakness;
• (a disease that causes general muscle weakness, including in some cases muscles involved in breathing) or ocular myasthenia (a disease that causes muscle weakness in the eyes), as statins can sometimes exacerbate the symptoms of the disease or lead to the development of myasthenia (see section 4);
• ;
• ;
• . You should read the leaflet carefully, even if you have taken other cholesterol-lowering medicines before;
• , e.g., ritonavir with lopinavir and (or) atazanavir, you should read the information in the section: "Ridlip and other medicines";
• (an antibiotic). Taking fusidic acid at the same time as Ridlip can lead to severe muscle damage (rhabdomyolysis); see the section "Ridlip and other medicines";
• (because the doctor must choose an appropriate initial dose of Ridlip for the patient);
• ;
• (Japanese, Chinese, Filipino, Vietnamese, Korean, or Indian). In these patients, the doctor will determine the appropriate initial dose of Ridlip.

If any of the above situations apply to the patient (or the patient has doubts):

Do not take Ridlip at a dose of 40 mg (the highest dose) and before taking Ridlip at any other dose, consult your doctor or pharmacist.

Severe skin reactions have been reported in association with the use of rosuvastatin-containing medicines, including Stevens-Johnson syndrome and drug reaction with eosinophilia and systemic symptoms (DRESS). If the patient notices any of the symptoms described in section 4, they should stop taking Ridlip and consult their doctor immediately.
In a small number of patients, statins may affect liver function. To confirm this effect, a blood test is performed to check liver enzyme activity. Usually, the doctor recommends performing a liver enzyme activity test in the blood before starting and during treatment with Ridlip.
Patients with diabetes or those at risk of developing diabetes will be under close medical supervision while taking this medicine. Patients who have high blood sugar and fat levels, are overweight, and have high blood pressure may be at risk of developing diabetes.

Children and adolescents

• : Ridlip should not be used in children under 6 years old.
• : Ridlip at a dose of 40 mg is not suitable for use in children and adolescents under 18 years old.

Ridlip and other medicines

You should tell your doctor or pharmacist about all medicines you are currently taking or have recently taken, as well as any medicines you plan to take.
You should tell your doctor if you are taking:

• cyclosporin (used, for example, after organ transplantation),
• blood thinners: e.g., warfarin, acenocoumarol, or fluindione (their blood-thinning effect, as well as the risk of bleeding, may be increased if taken at the same time as rosuvastatin), ticagrelor, or clopidogrel,
• a fibrate (such as gemfibrozil, fenofibrate) or any other cholesterol-lowering medicine (e.g., ezetimibe),
• medicines used to treat indigestion (used to neutralize stomach acid),
• erythromycin (an antibiotic), fusidic acid (an antibiotic - see below and the section "Warnings and precautions"),
• oral contraceptives,
• regorafenib (used to treat cancer),
• darolutamide (used to treat cancer),
• capmatinib (used to treat cancer),
• hormone replacement therapy,
• fostamatinib (used to treat low platelet count),
• febuxostat (used to treat and prevent high levels of uric acid in the blood),
• teriflunomide (used to treat multiple sclerosis),
• any of the following medicines used to treat viral infections, including HIV or hepatitis C, taken alone or in combination with other medicines (see the section "Warnings and precautions"): ritonavir, lopinavir, atazanavir, sofosbuvir, voxilaprevir, ombitasvir, paritaprevir, dasabuvir, velpatasvir, grazoprevir, elbasvir, glecaprevir, pibrentasvir.

Ridlip may affect the action of these medicines or these medicines may affect the action of Ridlip.

If the patient needs to take fusidic acid orally to treat a bacterial infection, they should temporarily stop taking Ridlip. The doctor will inform the patient when they can safely start taking Ridlip again. Taking Ridlip with fusidic acid can rarely lead to muscle weakness, tenderness, or pain (rhabdomyolysis). More information on rhabdomyolysis can be found in section 4.

Ridlip should not be takenduring pregnancy or breastfeeding. If a patient becomes pregnant while taking Ridlip, they should stop taking it immediately and consult their doctor. While taking Ridlip, patients should avoid becoming pregnant and use effective methods of contraception.
Before taking any medicine, patients should consult their doctor or pharmacist.

Driving and using machines

Most people can drive and use machines while taking Ridlip - it will not affect their ability. However, some patients may experience dizziness while taking Ridlip. If this symptom occurs, the patient should consult their doctor before driving or using machines.
Ridlip contains lactose.
If the patient has been found to be intolerant to some sugars (lactose, i.e., milk sugar), they should inform their doctor before taking Ridlip.

Ridlip contains sodium

This medicine contains less than 1 mmol (23 mg) of sodium per tablet, which means it is essentially "sodium-free".
A full list of excipients can be found in the section: "Contents of the pack and other information".

3. How to take Ridlip

This medicine should always be taken as directed by your doctor. If you are unsure, consult your doctor or pharmacist.

Adults

Taking Ridlip to lower cholesterol levels

Initial dose

Treatment should be started with a dose of 5 mg or 10 mg, even if the patient has previously taken higher doses of other statins. The size of the initial dose depends on:

• cholesterol levels,
• the degree of risk of heart attack or stroke in the patient,
• the presence of factors that increase the patient's susceptibility to adverse effects.

You should ask your doctor which initial dose of Ridlip is most suitable for you.
The doctor may decide to use a dose of 5 mg as the initial dose if:

• the patient is of Asian origin(Japanese, Chinese, Filipino, Vietnamese, Korean, or Indian),
• the patient is over 70 years old,
• the patient has moderately severe kidney disease,
• the patient is at risk of muscle diseases and pain (myopathy).

Increasing the dose and maximum daily dose

The doctor may decide to increase the dose so that it is suitable for the patient's needs.
If the patient started treatment with a dose of 5 mg, the doctor may decide to increase it to 10 mg, and then to 20 mg or 40 mg if necessary. If the patient started treatment with a dose of 10 mg, the doctor may decide to increase it to 20 mg, and then to 40 mg if necessary. The treatment period with a fixed dose between each dose increase is 4 weeks.
The maximum daily dose of Ridlip is 40 mg. It is used in patients with high cholesterol levels and a high risk of heart attack or stroke, in whom a dose of 20 mg was insufficient to lower cholesterol levels.

Taking Ridlip to reduce the risk of heart attack or stroke or similar health problems

The recommended daily dose is 20 mg, but the doctor may decide to reduce it if the patient has the factors described above.

Taking Ridlip in children and adolescents aged 6-17 years

The dose range for use in children and adolescents aged 6 to 17 years is 5 to 20 mg once daily. The usual initial dose is 5 mg once daily, and the doctor may gradually increase the dose to suit the patient's needs. The maximum daily dose of Ridlip in children aged 6 to 17 years is 10 mg or 20 mg, depending on the type of disease being treated. The medicine should be taken once daily. Ridlip at a dose of 40 mg should not be usedin children.

Taking the medicine

The tablet should be swallowed whole with water.
Ridlip should be taken once a dayat any time, with or without food.
It is recommended to take the medicine at the same time every day to make it easier to remember.

Cholesterol checks

To ensure that cholesterol levels have decreased and are normal, regular check-ups and blood tests should be performed.
The doctor may decide to increase the dose of Ridlip to suit the patient's needs.

Taking a higher dose of Ridlip than recommended

In case of taking a higher dose of Ridlip than recommended, you should consult your doctor or go to the nearest hospital.
If the patient is in the hospital or is being treated for another disease, they should inform their doctor or other medical staff that they are taking Ridlip.

Missing a dose of Ridlip

The next dose should be taken at the usual time. Do not take a double dose to make up for the missed dose.

Stopping Ridlip treatment

The patient should tell their doctor if they want to stop taking Ridlip. Cholesterol levels may rise again if Ridlip treatment is stopped.
If the patient has any further doubts about taking this medicine, they should consult their doctor or pharmacist.

4. Possible side effects

Like all medicines, Ridlip can cause side effects, although not everybody gets them.
It is important for the patient to know what side effects may occur. Usually, they are mild and disappear shortly after starting treatment.
The patient should stop taking Ridlip and seek medical help immediatelyif they experience the following allergic reactions:

• difficulty breathing with swelling of the face, lips, tongue, and (or) throat, or without;
• swelling of the face, lips, tongue, and (or) throat, which can cause difficulty swallowing;
• severe itching of the skin (with hives);
• red, flat patches, similar in shape to a target, or round patches on the torso, often with centrally located blisters, peeling of the skin, ulcers of the mouth, throat, nose, genitals, and eyes. These serious skin changes can be preceded by fever and flu-like symptoms (Stevens-Johnson syndrome);
• widespread rash, high fever, and swollen lymph nodes (DRESS or drug hypersensitivity syndrome).

The patient should stop taking Ridlip and consult their doctor immediately if they experience:

• muscle pain or other muscle symptomsthat persist longer than expected. Muscle symptoms occur more frequently in children and adolescents than in adult patients. As with other statins, a very small number of patients have experienced adverse effects on muscles. Rarely, these patients have experienced potentially life-threatening muscle damage (rhabdomyolysis);
• muscle rupture;
• symptoms of lupus-like syndrome(such as rash, joint disease, and hematological changes).

Common side effects (occurring in more than 1 in 100 but less than 1 in 10 patients)

• Headache
• Abdominal pain
• Constipation
• Nausea
• Muscle pain
• Weakness
• Dizziness
• Increased protein in the urine. This symptom usually resolves on its own and does not require stopping Ridlip (applies only to a dose of 40 mg).
• Diabetes. The risk of developing diabetes is higher if the patient has high blood sugar and fat levels, is overweight, and has high blood pressure. The treating doctor will monitor patients at risk while they are taking this medicine.

Uncommon side effects (occurring in more than 1 in 1,000 but less than 1 in 100 patients)

• Rash, itching, or other skin reactions.
• Increased protein in the urine. This symptom usually resolves on its own and does not require stopping Ridlip (applies only to doses of 5 mg, 10 mg, and 20 mg).

Rare side effects (occurring in more than 1 in 10,000 but less than 1 in 1,000 patients)

• Severe allergic reactions - symptoms include swelling of the face, lips, tongue, and (or) throat, difficulty swallowing and breathing, severe itching of the skin (with hives). If the patient suspects an allergic reaction, they should stop taking Ridlip and seek medical help immediately.
• Muscle damage in adults, the patient should exercise caution, i.e., stop taking Ridlip and consult their doctor immediatelyif they experience muscle pain or other muscle symptoms that persist longer than expected.
• Severe abdominal pain (pancreatitis).
• Increased liver enzyme activity in the blood.
• Increased tendency to bleed or bruise due to a low platelet count.
• Symptoms of lupus-like syndrome (such as rash, joint disease, and hematological changes).

Very rare side effects (occurring in less than 1 in 10,000 patients)

• Jaundice (yellowing of the skin and eyes)
• Hepatitis
• Blood in the urine
• Nerve damage to the arms and legs (felt as numbness)
• Joint pain
• Memory loss
• Breast enlargement in men (gynecomastia).

Side effects with unknown frequency:

• Diarrhea (loose stools)
• Cough
• Shortness of breath
• Swelling
• Sleep disorders (insomnia and nightmares)
• Sexual dysfunction
• Depression
• Breathing problems (persistent cough and (or) shortness of breath or fever)
• Tendon damage
• Persistent muscle weakness
• Myasthenia (a disease that causes general muscle weakness, including in some cases muscles involved in breathing)
• Ocular myasthenia (a disease that causes muscle weakness in the eyes). The patient should talk to their doctor if they experience weakness in their arms or legs, worsening after periods of activity, double vision, or drooping eyelids, difficulty swallowing, or shortness of breath.

Reporting side effects

If side effects occur, including any side effects not listed in the leaflet, the patient should tell their doctor or pharmacist, or nurse. Side effects can be reported directly to the Department of Adverse Reaction Monitoring of Medicinal Products, Medical Devices, and Biocides of the Office for Registration of Medicinal Products, Medical Devices, and Biocides:
Jerozolimskie Avenue 181C
02-222 Warsaw
tel.: 22 49-21-301
fax: 22 49-21-309
Website: https://smz.ezdrowie.gov.pl
Side effects can also be reported to the marketing authorization holder.
Reporting side effects will help to gather more information on the safety of the medicine.

5. How to store Ridlip

• Keep out of the sight and reach of children.
• Do not use Ridlip after the expiry date stated on the packaging. The expiry date refers to the last day of the month.
• Do not store above 30°C. Store in the original packaging.

Medicines should not be disposed of via wastewater or household waste. The patient should ask their pharmacist how to dispose of medicines that are no longer needed. This will help protect the environment.

6. Contents of the pack and other information

What Ridlip contains

The active substance of Ridlip is rosuvastatin. Ridlip contains calcium rosuvastatin in a dose equivalent to 5 mg, 10 mg, 20 mg, or 40 mg of rosuvastatin.
The other ingredients are: lactose monohydrate, microcrystalline cellulose, sodium citrate, magnesium stearate, crospovidone
Coating:
Film-coated tablets, 5 mg
Opadry Yellow 02B82338 [hypromellose 5cP, titanium dioxide (E171), Macrogol 400, yellow iron oxide (E172)]
Film-coated tablets, 10 mg, 20 mg, 40 mg
Opadry Pink 03B24082 [hypromellose 6 cP, titanium dioxide (E171), Macrogol 400, red iron oxide (E172)]

What Ridlip looks like and contents of the pack

Ridlip, 5 mg, light yellow to yellow, round, film-coated tablets with the inscription "RT 1" on one side and smooth on the other side.
Ridlip, 10 mg, light pink to pink, round, film-coated tablets with the inscription "RT 2" on one side and smooth on the other side.
Ridlip, 20 mg, light pink to pink, round, film-coated tablets with the inscription "RT 3" on one side and smooth on the other side.
Ridlip, 40 mg, light pink to pink, oval, film-coated tablets with the inscription "RT 4" on one side and smooth on the other side.
Ridlip is available in blister packs of 28, 56, and 90 tablets in a cardboard box.

Marketing authorization holder:

Ranbaxy (Poland) Sp. z o.o.
Idzikowskiego 16
00-710 Warsaw
Poland
Tel.: +48 22 642 07 75

Manufacturer:

Sun Pharmaceutical Industries Europe B.V., Polarisavenue 87, 2132 JH Hoofddorp, Netherlands
Terapia SA, 124 Fabricii Street, 400632 Cluj-Napoca, Cluj County, Romania

Date of last revision of the leaflet: